CN101589024B - 小沟结合物 - Google Patents

小沟结合物 Download PDF

Info

Publication number
CN101589024B
CN101589024B CN200780043350.4A CN200780043350A CN101589024B CN 101589024 B CN101589024 B CN 101589024B CN 200780043350 A CN200780043350 A CN 200780043350A CN 101589024 B CN101589024 B CN 101589024B
Authority
CN
China
Prior art keywords
methyl
amino
carbonyl
pyrrol
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200780043350.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN101589024A (zh
Inventor
A·哈拉夫
C·萨克林
R·韦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Strathclyde
Original Assignee
University of Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Strathclyde filed Critical University of Strathclyde
Publication of CN101589024A publication Critical patent/CN101589024A/zh
Application granted granted Critical
Publication of CN101589024B publication Critical patent/CN101589024B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN200780043350.4A 2006-09-30 2007-09-28 小沟结合物 Expired - Fee Related CN101589024B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0619325.4A GB0619325D0 (en) 2006-09-30 2006-09-30 New compounds
GB0619325.4 2006-09-30
PCT/GB2007/003698 WO2008038018A1 (en) 2006-09-30 2007-09-28 Novel minor groove binders

Publications (2)

Publication Number Publication Date
CN101589024A CN101589024A (zh) 2009-11-25
CN101589024B true CN101589024B (zh) 2014-01-01

Family

ID=37434989

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200780043350.4A Expired - Fee Related CN101589024B (zh) 2006-09-30 2007-09-28 小沟结合物

Country Status (10)

Country Link
US (1) US8012967B2 (enExample)
EP (1) EP2066627B1 (enExample)
JP (1) JP5564257B2 (enExample)
CN (1) CN101589024B (enExample)
CA (1) CA2664847C (enExample)
DK (1) DK2066627T3 (enExample)
ES (1) ES2443720T3 (enExample)
GB (2) GB0619325D0 (enExample)
PL (1) PL2066627T3 (enExample)
WO (1) WO2008038018A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9072535B2 (en) 2011-05-27 2015-07-07 Ethicon Endo-Surgery, Inc. Surgical stapling instruments with rotatable staple deployment arrangements
WO2011150156A2 (en) 2010-05-26 2011-12-01 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
CZ305332B6 (cs) * 2013-10-25 2015-08-05 Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové Použití derivátů pyrazinu a jejich isosterů jako sloučenin vážících se do malého žlábku DNA
CN105732583B (zh) * 2016-03-25 2018-05-04 苏州麦迪耐斯医药科技有限公司 一种治疗脑胶质母细胞瘤的靶向化合物
CN109715637B (zh) 2016-07-22 2022-04-05 百时美施贵宝公司 葡萄糖激酶激活剂及其使用方法
WO2018047148A1 (en) 2016-09-12 2018-03-15 Novartis Ag Compounds for the inhibition of mirna
JP7477858B2 (ja) * 2020-03-05 2024-05-02 国立大学法人電気通信大学 急性ｔリンパ芽球性白血病若しくはリンパ腫、又は急性骨髄性白血病治療用医薬組成物
GB202114032D0 (en) 2021-09-30 2021-11-17 Univ Strathclyde Antivirals
GB202206931D0 (en) 2022-05-12 2022-06-29 Univ Strathclyde Compounds
CN115109113B (zh) * 2022-05-31 2023-06-27 上海应用技术大学 一种胆固醇类衍生物有机凝胶因子及其制备方法和应用
CN116514698A (zh) * 2023-04-10 2023-08-01 佛山奕安赛医药科技有限公司 一种沃诺拉赞中间体的制备方法及其应用

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1886481A (en) * 1927-11-07 1932-11-08 Soc Of Chemical Ind Unilaterally acylated diamines and process of making same
DE2331444A1 (de) 1973-06-20 1975-01-23 Hoechst Ag Neue styryl-benzoxazole, verfahren zu deren herstellung und ihre verwendung als optische aufhellungsmittel
US4665181A (en) 1984-05-17 1987-05-12 Pennwalt Corporation Anti-inflammatory phthalazinones
CA1308516C (en) * 1987-07-06 1992-10-06 J. William Lown Oligopeptide anticancer and antiviral agents
IL90337A0 (en) 1988-05-24 1989-12-15 Pfizer Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
US4919199A (en) * 1989-01-13 1990-04-24 The Atlantic Group, Inc. Multiple locking stake for tube bundle
FR2656608B1 (fr) 1989-12-28 1992-04-24 Roussel Uclaf Nouvelles polyamines benzoylees, leur procede de preparation et leur application comme fongicides.
US5273991A (en) * 1992-07-29 1993-12-28 Research Corporation Technologies, Inc. Imidazole-containing compositions and methods of use thereof analogs of distamycin
IT1263089B (it) * 1993-04-26 1996-07-24 Menarini Farma Ind Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.
US5698674A (en) * 1994-04-13 1997-12-16 The Regents Of The University Of California Triheterocyclic peptides capable of binding the minor and major grooves of DNA
GB9416005D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Peptidic compounds analogous to distamycin a and process for their preparation
US5637621A (en) * 1994-11-14 1997-06-10 Nzym, Inc. Methods and compositions for treating Botrytis infections
US5801155A (en) * 1995-04-03 1998-09-01 Epoch Pharmaceuticals, Inc. Covalently linked oligonucleotide minor grove binder conjugates
US5767142A (en) * 1996-03-20 1998-06-16 Rutgers, The State University Of New Jersey Trisbenzimidazoles useful as topoisomerase I inhibitors
GB9516943D0 (en) * 1995-08-18 1995-10-18 Cancer Soc Auckland Div Nz Inc Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
AU1596097A (en) 1996-02-02 1997-08-22 Pharmacia & Upjohn S.P.A. Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
US6506906B1 (en) * 1996-02-26 2003-01-14 California Institute Of Technology Preparation and use of bifunctional molecules having DNA sequence binding specificity
AU734715B2 (en) * 1996-02-26 2001-06-21 California Institute Of Technology Improved polyamides for binding in the minor groove of double stranded DNA
US6090947A (en) 1996-02-26 2000-07-18 California Institute Of Technology Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
US6143901A (en) 1996-07-31 2000-11-07 Genesoft, Inc. Complex formation between dsDNA and pyrrole imidazole polyamides
US6635417B1 (en) * 1996-07-31 2003-10-21 California Institute Of Technology Complex formation between DSDNA and oligomer of cyclic heterocycles
US5770617A (en) 1996-03-20 1998-06-23 Rutgers, The State University Of New Jersey Terbenzimidazoles useful as antifungal agents
US6060608A (en) * 1996-05-31 2000-05-09 The Scripps Research Institute Analogs of CC-1065 and the duocarmycins
US6258823B1 (en) * 1996-07-12 2001-07-10 Ariad Pharmaceuticals, Inc. Materials and method for treating or preventing pathogenic fungal infection
JP2002515057A (ja) * 1996-08-01 2002-05-21 カリフォルニア・インスティチュート・オブ・テクノロジー ポリアミドｄｎａ結合リガンドによる遺伝子発現の阻害
GB9623522D0 (en) 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
US6251933B1 (en) * 1996-12-13 2001-06-26 The Cancer Research Campaign Technology Limited Seco precursors of cyclopropylindolines and their use as prodrugs
AU8572898A (en) * 1997-07-17 1999-02-10 Tm Technologies, Inc. Methods and compositions for modulating melting temperatures of nucleic acids
JPH11189594A (ja) 1997-12-25 1999-07-13 Mitsui Chem Inc アクリル酸誘導体を側鎖にもつピロリルベンズイミダゾール誘導体
US6008247A (en) * 1998-02-27 1999-12-28 The University Of North Carolina At Chapel Hill 2,4-bis[(4-amidino)phenyl]furans as anti-Pneumocystis carinii agents
AU758563B2 (en) * 1998-08-20 2003-03-27 University Of North Carolina At Chapel Hill, The Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
GB9818731D0 (en) * 1998-08-27 1998-10-21 Univ Portsmouth Compounds
DK1193270T3 (da) * 1998-08-27 2003-09-15 Spirogen Ltd Pyrrolobenzodiazepiner
GB9818730D0 (en) * 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
US6326395B1 (en) * 1998-09-17 2001-12-04 Duke University Antifungal activity of dicationic molecules
GB9908828D0 (en) * 1999-04-16 1999-06-16 Univ Reading The Compounds
ES2282127T3 (es) * 1999-07-08 2007-10-16 University Of North Carolina At Chapel Hill Nuevos profarmacos para amidinas anticrobianas.
AU7381600A (en) 1999-09-17 2001-04-17 Genelabs Technologies, Inc. Covalently linked dimeric dna binding molecules
MXPA02005937A (es) * 1999-12-20 2004-08-12 Univ North Carolina Compuestos de diamina como aglutinantes de surco menor.
JP2001181279A (ja) 1999-12-28 2001-07-03 Mitsui Chemicals Inc ベンゾフラニルピロールカルボキシアミド誘導体
CN1427839A (zh) 2000-03-16 2003-07-02 根索福特股份有限公司 含有核酸结合部分的带电荷化合物及其用途
AU2001262974A1 (en) 2000-05-03 2001-11-12 The Scripps Research Institute Dna alkylating agent and activation thereof
AU2001269885A1 (en) 2000-06-14 2001-12-24 The Scripps Research Institute Distamycin a analogs
EP1294713A2 (en) 2000-06-27 2003-03-26 Genelabs Technologies, Inc. Compounds possessing antibacterial, antifungal or antitumor activity
GB0015904D0 (en) 2000-06-28 2000-08-23 Hoffmann La Roche Inhibitors of HPV E1 helicase enzyme
AU2001282070A1 (en) * 2000-07-11 2002-01-21 Universite De Geneve Linked, sequence-specific DNA-binding molecules
JP5010089B2 (ja) * 2000-09-19 2012-08-29 スピロジェン リミテッド Ｃｃ−１０６５およびデュオカルマイシンのアキラルアナログの組成物およびその使用方法
AU2002310764A1 (en) 2001-05-21 2002-12-03 Universite De Geneve Sequence-specific dna binding compounds and their use in targeting telomeres and other dna sequences
WO2002101007A2 (en) 2001-06-13 2002-12-19 Genesoft Pharmaceuticals, Inc Antipathogenic benzamide compounds
US6777425B2 (en) 2001-06-13 2004-08-17 Genesoft Pharmaceuticals, Inc. Isoquinoline compounds having antiinfective activity
JP2003089652A (ja) 2001-09-20 2003-03-28 Meiji Seika Kaisha Ltd 抗口腔カンジダ症組成物
US20030187026A1 (en) * 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
GB0130868D0 (en) * 2001-12-24 2002-02-06 Univ Strathclyde New compounds
WO2003070450A1 (en) 2002-02-21 2003-08-28 Riken High-strength film of polyhydroxyalkanoic acid and process for producing the same
WO2003072058A2 (en) 2002-02-27 2003-09-04 The Government Of The United States Of America, Representated By The Secretary, Deparment Of Health And Human Services Dna-binding polyamide drug conjugates
WO2003078450A2 (en) 2002-03-11 2003-09-25 Epoch Biosciences, Inc. Negatively charged minor groove binders
ES2384568T3 (es) 2003-07-30 2012-07-09 Kyowa Hakko Kirin Co., Ltd. Derivados de indazol

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Toshikaza Bando et al.Highly Efficient Sequence-Specific DNA interstrand Cross-Linking by Pyrrole/imidazole CPI Conjugates.《J.AM.CHEM.SOC.》.2003,第125卷 *
Zhi-Fu Tao et al.Highly Cooperative DNA Dialkylation by the Homodimer of Imidazole-Pyrrole Diamide-CPI Conjugate with Vinyl Linker.《J.Am.Chem.Soc.》.2000,第122卷 *

Also Published As

Publication number Publication date
EP2066627A1 (en) 2009-06-10
CA2664847C (en) 2014-12-02
CA2664847A1 (en) 2008-04-03
GB0906908D0 (en) 2009-06-03
EP2066627B1 (en) 2013-10-23
GB2455479A (en) 2009-06-17
JP2010505757A (ja) 2010-02-25
GB0619325D0 (en) 2006-11-08
JP5564257B2 (ja) 2014-07-30
CN101589024A (zh) 2009-11-25
DK2066627T3 (da) 2014-01-27
US20100016311A1 (en) 2010-01-21
GB2455479C (en) 2012-05-16
PL2066627T3 (pl) 2014-05-30
WO2008038018A1 (en) 2008-04-03
HK1138281A1 (en) 2010-08-20
ES2443720T3 (es) 2014-02-20
US8012967B2 (en) 2011-09-06
GB2455479B (en) 2009-10-28

Similar Documents

Publication Publication Date Title
CN101589024B (zh) 小沟结合物
CN102574818B (zh) Apaf-1抑制剂化合物
CN101583598B (zh) 具有IκB激酶β抑制活性的新型吲哚衍生物
CN100455586C (zh) 嘧啶并噻吩化合物
US8686015B2 (en) Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
US9029402B2 (en) Pyrrole inhibitors of S-nitrosoglutathione reductase
US11542273B2 (en) Amide compound having bet proteolysis-inducing action and medicinal application thereof
CN116867785A (zh) 化合物及其用途
JP6474736B2 (ja) アルビシジン誘導体、その使用および合成
JP2003529584A (ja) Ｂａｘ阻害剤としての医薬として活性なピロリジン誘導体
TR201906325T4 (tr) Tetrazolon sübstitüeli dihidropiridinon MGAT2 inhibitörleri.
JP2010174023A (ja) Ｄｎａ副溝結合化合物
CN117794580A (zh) 多肽偶联药物
WO2015004610A1 (en) 1,5-dihydropyrrol-2-one derivatives as inhibitors of p53-mdm2/mdm4 protein-protein interaction
CN105658625A (zh) 作为细胞坏死阻碍剂的吲哚酰胺化合物
Khalaf et al. Synthesis and antimicrobial activity of some netropsin analogues
HK1138281B (en) Minor groove binders
US20250295652A1 (en) Inhibitors of Molluscum Contagiosum Infection and Methods Using the Same
WO2011057477A1 (zh) 四肽类似物及其制备和应用
KR20090014295A (ko) 레닌 억제제로서의 피롤리딘 화합물
CN118339145A (zh) 双环稠环衍生物或其盐以及包含其的药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1138281

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1138281

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140101